HDAC6 bridges the gap

被引：1
|
作者：
Love, R
机构：
来源：
LANCET NEUROLOGY | 2004年 / 3卷 / 02期
关键词：
D O I：
10.1016/S1474-4422(03)00649-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [31] Curriculum vitae of HDAC6 in solid tumors
    Zheng, Yi-Chao
    Kang, Hui-Qin
    Wang, Bo
    Zhu, Yuan-Zai
    Mamun, M. A. A.
    Zhao, Long-Fei
    Nie, Hai-Qian
    Liu, Ying
    Zhao, Li-Juan
    Zhang, Xiao-Nan
    Gao, Mei-Mei
    Jiang, Dan-Dan
    Liu, Hong-Min
    Gao, Ya
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 230
  • [32] Endeavors toward a specific inhibitor for HDAC6
    Kato, Tamaki
    Jose, Binoy
    Okamura, Shinji
    Sumida, Yuko
    Yoshida, Minoru
    Nishino, Norikazu
    PEPTIDE REVOLUTION: GENOMICS, PROTEOMICS & THERAPEUTICS, 2004, : 524 - 525
  • [33] Cytosolic HDAC6 is accumulated in cystic kidneys
    Li, Xin
    Qi, Na
    Li, Lin
    Wu, Ming
    Mei, Changlin
    KIDNEY INTERNATIONAL, 2016, 90 (03) : 705 - 705
  • [34] Mechanism and consequences of HDAC6 regulation by RanBPM
    Salemi, Louisa
    Wang, Xu
    Hess, David
    Schild-Poulter, Caroline
    CANCER RESEARCH, 2016, 76
  • [35] Histone Deacetylase 6 (HDAC6) Is an Independent Deacetylase for α-Tubulin
    Zhao, Zhiqiang
    Xu, Hang
    Gong, Weimin
    PROTEIN AND PEPTIDE LETTERS, 2010, 17 (05): : 555 - 558
  • [36] Effects of structurally distinct human HDAC6 and HDAC6/HDAC8 inhibitors against S. mansoni larval and adult worm stages
    Gimmelli, Roberto
    Papoff, Giuliana
    Saccoccia, Fulvio
    Lalli, Cristiana
    Gemma, Sandra
    Campiani, Giuseppe
    Ruberti, Giovina
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (02):
  • [37] Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
    Zeleke, Tizita Z.
    Pan, Qingfei
    Chiuzan, Codruta
    Onishi, Maika
    Li, Yuxin
    Tan, Haiyan
    Alvarez, Mariano J.
    Honan, Erin
    Yang, Min
    Chia, Pei Ling
    Mukhopadhyay, Partha
    Kelly, Sean
    Wu, Ruby
    Fenn, Kathleen
    Trivedi, Meghna S.
    Accordino, Melissa
    Crew, Katherine D.
    Hershman, Dawn L.
    Maurer, Matthew
    Jones, Simon
    High, Anthony
    Peng, Junmin
    Califano, Andrea
    Kalinsky, Kevin
    Yu, Jiyang
    Silva, Jose
    NATURE CANCER, 2023, 4 (02) : 257 - +
  • [38] Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
    Tizita Z. Zeleke
    Qingfei Pan
    Codruta Chiuzan
    Maika Onishi
    Yuxin Li
    Haiyan Tan
    Mariano J. Alvarez
    Erin Honan
    Min Yang
    Pei Ling Chia
    Partha Mukhopadhyay
    Sean Kelly
    Ruby Wu
    Kathleen Fenn
    Meghna S. Trivedi
    Melissa Accordino
    Katherine D. Crew
    Dawn L. Hershman
    Matthew Maurer
    Simon Jones
    Anthony High
    Junmin Peng
    Andrea Califano
    Kevin Kalinsky
    Jiyang Yu
    Jose Silva
    Nature Cancer, 2023, 4 : 257 - 275
  • [39] PET imaging assist investigation of HDAC6 expression change in MDD and evaluating antidepressant efficacy of a newly developed HDAC6 inhibitor
    Zhong, Xiao
    Wu, Xiaoai
    Zhou, Yanting
    Wu, Rui
    Yang, Jingyi
    Yin, Honghai
    Meng, Hui
    Xie, Weiyao
    Liu, Gang
    Wang, Changning
    Bai, Ping
    Zhang, Wei
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280
  • [40] DISCOVERY OF A NEW HDAC6 INHIBITOR FOR THE TREATMENT OF GLIOBLASTOMA
    Auzmendi-Iriarte, J.
    Saenz-Antonanzas, A.
    Andermatten, J.
    Elua-Pinin, A.
    Aldaba, E.
    Vara, Y.
    Matheu, A.
    NEURO-ONCOLOGY, 2019, 21 : 53 - 54
12345